AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8129127 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 35
Study 2916912 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional back strengthening program consisting mainly of antigravity upper back extension exercises in the prone position.
Number of subjects: 50
Study 2916912 — intervention group
Group type: COMPARATOR
Intervention: Usual athletic and daily physical activities (Control group).
Number of subjects: 50
Study 4901344 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim 320 mg and Sulphamethoxazole 1,600 mg a day
Number of subjects: 50
Study 4901344 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin 2 g a day
Number of subjects: 50
Study 31953696 — intervention group
Group type: EXPERIMENTAL
Intervention: TCbHP (6 cycles)
Number of subjects: 204
Study 31953696 — intervention group
Group type: EXPERIMENTAL
Intervention: TCbHP (4 cycles) followed by T-DM1+P (4 cycles)
Number of subjects: 204
Study 31953696 — intervention group
Group type: EXPERIMENTAL
Intervention: T-DM1+P (4 cycles)
Number of subjects: 204
Study 31953696 — intervention group
Group type: EXPERIMENTAL
Intervention: T-DM1+P (4 cycles) in responders
Number of subjects: 204
Study 31953696 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC (4 cycles) in nonresponders
Number of subjects: 204
Study 30817246 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-body positive pressure (LBPP) at 40 mmHg when supine
Number of subjects: 22
Study 30817246 — intervention group
Group type: EXPERIMENTAL
Intervention: LBPP plus 10° Trendelenburg position
Number of subjects: 22
Study 30817246 — intervention group
Group type: EXPERIMENTAL
Intervention: Returning to supine with LBPP
Number of subjects: 22
Study 30817246 — intervention group
Group type: COMPARATOR
Intervention: Control (laying supine for equal time)
Number of subjects: 22
Study 28477490 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal tumours
Number of subjects: 3338
Study 28477490 — intervention group
Group type: COMPARATOR
Intervention: Unifocal tumours
Number of subjects: 3338
Study 25147364 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (2 mg/kg)
Number of subjects: 40
Study 25147364 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine (0.1 mg/kg)
Number of subjects: 40
Study 23345634 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use in the acute phase after IV thrombolysis
Number of subjects: 2072
Study 22032731 — intervention group
Group type: EXPERIMENTAL
Intervention: MLPA assay for predicting BRCAness
Number of subjects: 84
Study 22032731 — intervention group
Group type: EXPERIMENTAL
Intervention: MLPA assay applied to independent validation set
Number of subjects: 84
Study 22032731 — intervention group
Group type: EXPERIMENTAL
Intervention: MLPA test applied to 46 breast tumour samples from a randomized clinical trial
Number of subjects: 84
Study 19253204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d.
Number of subjects: 80
Study 19253204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 50 mg b.i.d.
Number of subjects: 80
Study 19253204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 19253204 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d. and 50 mg b.i.d.
Number of subjects: 80
Study 16633143 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (8 mg/d)
Number of subjects: 40
Study 16633143 — intervention group
Group type: COMPARATOR
Intervention: Fluvoxamine (150 mg/d)
Number of subjects: 40
Study 16633143 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 40
Study 16633143 — intervention group
Group type: COMPARATOR
Intervention: Fluvoxamine
Number of subjects: 40
Study 15283825 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (20‐25 mg x kg(‐1)) preoperatively
Number of subjects: 60
Study 15283825 — intervention group
Group type: COMPARATOR
Intervention: Caudal bupivacaine
Number of subjects: 60
Study 15283825 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol (20‐25 mg x kg(‐1)) postoperatively
Number of subjects: 60
Study 11419378 — intervention group
Group type: EXPERIMENTAL
Intervention: Special jury instructions not to discount awards for uncertainty about the defendant's fault
Number of subjects: 0
Study 11419378 — intervention group
Group type: EXPERIMENTAL
Intervention: Special jury instructions not to increase awards to punish the defendant's carelessness
Number of subjects: 0
Study 11419378 — intervention group
Group type: COMPARATOR
Intervention: Bifurcation of liability and compensation decisions
Number of subjects: 0
Study 11419378 — intervention group
Group type: EXPERIMENTAL
Intervention: Discounting process
Number of subjects: 0
Study 9244208 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 69
Study 9244208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 8386917 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nedocromil sodium four times daily for 12 weeks
Number of subjects: 209
Study 8386917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 8386917 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nedocromil sodium
Number of subjects: 209
Study 3122518 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol administered 30 min prior to bypass
Number of subjects: 2
Study 3122518 — intervention group
Group type: COMPARATOR
Intervention: Mannitol at the start of bypass (control group)
Number of subjects: 2
Study 31977698 — intervention group
Group type: EXPERIMENTAL
Intervention: Submandibular anesthesia through catheter perfusion, lingual nerve block, and subcutaneous infiltration anesthesia
Number of subjects: 38
Study 31977698 — intervention group
Group type: COMPARATOR
Intervention: Lingual nerve block and subcutaneous infiltration anesthesia
Number of subjects: 38
Study 30132686 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Prolonged-Release Melatonin (PedPRM) 2/5 mg nightly for 39 weeks
Number of subjects: 95
Study 30132686 — intervention group
Group type: COMPARATOR
Intervention: Pediatric Prolonged-Release Melatonin (PedPRM)
Number of subjects: 95
Study 27566331 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeting systolic blood pressure (SBP) <120 mmHg
Number of subjects: 0
Study 27566331 — intervention group
Group type: COMPARATOR
Intervention: Targeting systolic blood pressure (SBP) <140 mmHg
Number of subjects: 0
Study 24198051 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (5-10 mg for 3 months)
Number of subjects: 20
Study 24198051 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe (10 mg for 3 months)
Number of subjects: 20
Study 22510898 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet‐leukocyte‐enriched plasma spray
Number of subjects: 12
Study 22510898 — intervention group
Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 12
Study 20149066 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainees
Number of subjects: 128
Study 20149066 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced Community Oral Health Workers (COHW)
Number of subjects: 128
Study 20149066 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional dentists
Number of subjects: 128
Study 18545248 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation (SCT)
Number of subjects: 0
Study 18545248 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective SCT trials
Number of subjects: 0
Study 15205717 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin, 20 mg per day (n=24)
Number of subjects: 49
Study 15205717 — intervention group
Group type: COMPARATOR
Intervention: Matching placebos (n=25)
Number of subjects: 49
Study 11723148 — intervention group
Group type: EXPERIMENTAL
Intervention: 125‐mg b.i.d. doses of levodopa/benserazide (Madopar)
Number of subjects: 17
Study 11723148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 10325653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional knowledge, attitude and practice survey
Number of subjects: 965
Study 10325653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional knowledge acquisition attitude
Number of subjects: 965
Study 10325653 — intervention group
Group type: EXPERIMENTAL
Intervention: Food frequency survey
Number of subjects: 965
Study 10325653 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of nutritional information
Number of subjects: 965
Study 8267134 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol treatment (plasma levels varied, duration 6 weeks)
Number of subjects: 45
Study 3438116 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesthetic instruction
Number of subjects: 20
Study 3438116 — intervention group
Group type: COMPARATOR
Intervention: Visual instruction
Number of subjects: 20
Study 31206569 — intervention group
Group type: COMPARATOR
Intervention: Mucoperiosteal harvesting technique (Group A)
Number of subjects: 20
Study 31206569 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal harvesting technique (Group B)
Number of subjects: 20
Study 31206569 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 20
Study 29442524 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)
Number of subjects: 16485
Study 29442524 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalized AECOPD
Number of subjects: 16485
Study 26930055 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSIP (Attempted Suicide Short Intervention Program)
Number of subjects: 120
Study 26930055 — intervention group
Group type: COMPARATOR
Intervention: Control (treatment as usual)
Number of subjects: 120
Study 25443802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloud-based manometers integrated with physician order entry systems
Number of subjects: 36
Study 25443802 — intervention group
Group type: COMPARATOR
Intervention: Typical BP recording sheets
Number of subjects: 36
Study 22591589 — intervention group
Group type: EXPERIMENTAL
Intervention: Short‐course image‐guided radiotherapy (RT)
Number of subjects: 119
Study 22591589 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (RT)
Number of subjects: 119
Study 22591589 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-RT Scapula alata (SA)
Number of subjects: 119
Study 22591589 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-RT characteristics
Number of subjects: 119
Study 21126970 — intervention group
Group type: EXPERIMENTAL
Intervention: High vegetable consumption in childhood
Number of subjects: 1622
Study 21126970 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistently high consumption of fruits and vegetables from childhood to adulthood
Number of subjects: 1622
Study 21126970 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of lifestyle risk factors in childhood (lowest quintile for vegetable consumption, fruit consumption, physical activity, and smoking)
Number of subjects: 1622
Study 17661330 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea purpurea
Number of subjects: 0
Study 17661330 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus membranaceus
Number of subjects: 0
Study 17661330 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycyrrhiza glabra
Number of subjects: 0
Study 17661330 — intervention group
Group type: EXPERIMENTAL
Intervention: Echinacea purpurea (daily use for at least 7 days)
Number of subjects: 0
Study 15882217 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% benzydamine hydrochloride and 0.05% cetylpyridinium chloride mouth rinse (BNZ+CPC)
Number of subjects: 0
Study 15882217 — intervention group
Group type: COMPARATOR
Intervention: CPC mouth rinse
Number of subjects: 0
Study 15882217 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 0
Study 11050634 — intervention group
Group type: EXPERIMENTAL
Intervention: High-viscosity ferristene formulations
Number of subjects: 113
Study 11050634 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 113
Study 11050634 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-contrast MRI
Number of subjects: 113
Study 9329701 — intervention group
Group type: EXPERIMENTAL
Intervention: Propentofylline (3 x 300 mg taken 1 hr before food)
Number of subjects: 1260
Study 9329701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1260
Study 8390009 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium acetate
Number of subjects: 15
Study 8390009 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 15
Study 3564873 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (0.25%) continuously administered by infusion pump, 4‐6 ml h‐1, for 48 h
Number of subjects: 60
Study 3564873 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine, 2‐6 mg, at the end of operation and repeated on the first and second postoperative mornings
Number of subjects: 60
Study 3564873 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine, 2‐6 mg per die, administered for 48 h continuously by infusion pump
Number of subjects: 60
Study 3564873 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular oxycodone (0.15 mg kg‐1) on request
Number of subjects: 60
Study 29617177 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 0
Study 29617177 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 0
Study 29617177 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 28198712 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 0
Study 25011643 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin-based topical haemostatic agent (Floseal)
Number of subjects: 48
Study 25011643 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 48
Study 23442748 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and treatment of asymptomatic carriers with artemether-lumefantrine during community screening campaigns.
Number of subjects: 18
Study 23442748 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 18
Study 23442748 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and treatment of asymptomatic carriers with artemether-lumefantrine during campaign 1.
Number of subjects: 18
Study 23442748 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and treatment of asymptomatic carriers with artemether-lumefantrine during campaigns 2 and 3.
Number of subjects: 18
Study 23442748 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and treatment of asymptomatic carriers with artemether-lumefantrine during campaign 4.
Number of subjects: 18
Study 21470880 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf compression during MRA
Number of subjects: 61
Study 21470880 — intervention group
Group type: COMPARATOR
Intervention: Conventional MRA without calf compression
Number of subjects: 61
Study 18422947 — intervention group
Group type: COMPARATOR
Intervention: Aerobic cycling plus sham progressive resistance training (n=13)
Number of subjects: 52
Study 18422947 — intervention group
Group type: COMPARATOR
Intervention: Sham cycling plus progressive resistance training (n=13)
Number of subjects: 52
Study 18422947 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic cycling plus progressive resistance training (n=14)
Number of subjects: 52
Study 18422947 — intervention group
Group type: COMPARATOR
Intervention: Sham cycling plus sham progressive resistance training (n=12)
Number of subjects: 52
Study 16411280 — intervention group
Group type: EXPERIMENTAL
Intervention: Time Domain Fitting (TDF) method
Number of subjects: 72
Study 16411280 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency Domain Analysis (FDA) method
Number of subjects: 72
Study 16411280 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TDF and FDA methods
Number of subjects: 72
Study 16411280 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 72
Study 16411280 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations
Number of subjects: 72
Study 12671888 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 200 mg
Number of subjects: 80
Study 12671888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 10846910 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil (0.4 mg/kg)
Number of subjects: 40
Study 10846910 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (1.5 mg/kg)
Number of subjects: 40
Study 10846910 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Urapidil and Lidocaine
Number of subjects: 40
Study 9332475 — intervention group
Group type: COMPARATOR
Intervention: Normal cultures (without aphidicolin)
Number of subjects: 0
Study 9332475 — intervention group
Group type: COMPARATOR
Intervention: Cultures with aphidicolin
Number of subjects: 0
Study 9332475 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer individuals in both types of cultures
Number of subjects: 0
Study 9332475 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine cervix cancer individuals in both types of cultures
Number of subjects: 0
Study 8401358 — intervention group
Group type: EXPERIMENTAL
Intervention: Propantheline 30 mg orally every 6 h for six doses
Number of subjects: 12
Study 8401358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29909565 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical pimecrolimus, applied four times daily for 4 weeks
Number of subjects: 30
Study 29909565 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone cream, applied four times daily for 4 weeks
Number of subjects: 30
Study 29656933 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical Impedance Analysis (BIA)
Number of subjects: 30
Study 29656933 — intervention group
Group type: EXPERIMENTAL
Intervention: Skinfold Thickness Measurement (STM)
Number of subjects: 30
Study 29656933 — intervention group
Group type: COMPARATOR
Intervention: Dual-Energy X-ray Absorptiometry (DXA)
Number of subjects: 30
Study 27462136 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 0.5 mg daily for two weeks
Number of subjects: 26
Study 27462136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 25169639 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for benign struma ovarii (25 cystectomies, 15 unilateral salpingo-oophorectomies, 2 bilateral salpingo-oophorectomies, 22 hysterectomies with salpingo-oophorectomy)
Number of subjects: 68
Study 25169639 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for malignant struma ovarii (1 fertility-sparing staging surgery, 2 unilateral salpingo-oophorectomies, 1 hysterectomy with bilateral salpingo-oophorectomy)
Number of subjects: 68
Study 25169639 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy after surgery for malignant struma ovarii (2 patients)
Number of subjects: 68
Study 22153890 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab and trastuzumab plus docetaxel (group B)
Number of subjects: 417
Study 22153890 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab plus docetaxel (group A)
Number of subjects: 417
Study 22153890 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab plus docetaxel (group D)
Number of subjects: 417
Study 22153890 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab and trastuzumab (group C)
Number of subjects: 417
Study 22153890 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 417
Study 22153890 — intervention group
Group type: COMPARATOR
Intervention: Group C
Number of subjects: 417
Study 20682679 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 1759
Study 20682679 — intervention group
Group type: COMPARATOR
Intervention: Usual care (diabetes support and education [DSE])
Number of subjects: 1759
Study 17878180 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (formula containing Bifidobacterium bifidum with Streptococcus thermophilus - 2.5 x 10(10) colony forming units)
Number of subjects: 77
Study 17878180 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (control group)
Number of subjects: 77
Study 17878180 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 77
Study 15753235 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg x 1)
Number of subjects: 12
Study 12005316 — intervention group
Group type: COMPARATOR
Intervention: Normally developing children
Number of subjects: 17
Study 12005316 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with spastic diplegia
Number of subjects: 17
Study 12005316 — intervention group
Group type: COMPARATOR
Intervention: Normally developing adults
Number of subjects: 17
Study 10610828 — intervention group
Group type: EXPERIMENTAL
Intervention: ABI group (clinical surveillance with distal pressure measurements)
Number of subjects: 344
Study 10610828 — intervention group
Group type: COMPARATOR
Intervention: DD group (duplex scanning)
Number of subjects: 344
Study 10610828 — intervention group
Group type: EXPERIMENTAL
Intervention: ABI group (with protocol adherence)
Number of subjects: 344
Study 10610828 — intervention group
Group type: COMPARATOR
Intervention: DD group (with protocol adherence)
Number of subjects: 344
Study 7806030 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 7
Study 7806030 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 7
Study 1672679 — intervention group
Group type: EXPERIMENTAL
Intervention: BRL 26830A
Number of subjects: 0
Study 1672679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6806155 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous mannitol (1 g/kg)
Number of subjects: 44
Study 6806155 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (32 mg stat, 8 mg qds)
Number of subjects: 44
Study 6806155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 44
Study 30482491 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal voice smoke alarms
Number of subjects: 176
Study 30482491 — intervention group
Group type: COMPARATOR
Intervention: Conventional residential high‐frequency tone smoke alarm
Number of subjects: 176